Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., L...

FDA Recall #D-0278-2025 — Class II — March 7, 2025

Recall #D-0278-2025 Date: March 7, 2025 Classification: Class II Status: Ongoing

Product Description

Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04

Reason for Recall

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Recalling Firm

Slate Run Pharmaceuticals — Columbus, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

56,790 bottles

Distribution

Product was distributed to 8 distributors who may have further distribute the product nationwide.

Code Information

Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated